Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice.
about
An in-depth analysis of original antigenic sin in dengue virus infectionYellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse ModelCharacterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus MacaquesAn adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypesPediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue VirusStructural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-ReactivityCross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISAVaccination with dengue virus-like particles induces humoral and cellular immune responses in mice.Proteomic identification of dengue virus binding proteins in Aedes aegypti mosquitoes and Aedes albopictus cells.Dengue and West Nile Virus Transmission in Children and Adults in Coastal Kenya.Antibody Prophylaxis Against Dengue Virus 2 Infection in Non-Human Primates.Dengue virus type-3 envelope protein domain III; expression and immunogenicity.Potential role for Toll-like receptor 4 in mediating Escherichia coli maltose-binding protein activation of dendritic cells.Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein.Nasal immunization with a fusion protein consisting of the hemagglutinin A antigenic region and the maltose-binding protein elicits CD11c(+) CD8(+) dendritic cells for induced long-term protective immunity.Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice
P2860
Q24606493-FD940E19-ACC5-4ED8-996D-1969469962B0Q27473317-F4B3F26A-0082-4AC1-9353-86DA9A27740EQ27477541-0BF78791-5785-490C-9468-8574BAE4B00DQ27478104-0B8977A5-E487-4819-8850-BA4CD5E7CCBFQ27484362-A3C72E8A-3CC6-463F-BF64-38CF51EEAC7FQ27678419-28E9D202-3075-43C1-8467-B15A97C19761Q34354665-02B11BAE-A65D-4236-B14E-3F2D5D9DD99CQ35081258-18B6F8C7-4C74-43EE-9981-18D67BAEB186Q35128995-53074CD2-B05C-4E57-AC48-1D6D3A7A7826Q37346709-C534BD76-18DD-4C90-BB9E-EA5731FDD91EQ38797690-D84C119E-ADC1-45A0-9790-F591C3663B22Q40081626-CD19D6E6-7481-444E-BC59-B8FBFAFE2093Q40168970-E4FA0E28-F0A2-457B-89C5-5B0444DA8C37Q40183650-3C5F1F9F-E935-4AE8-9CF0-7714F79FA924Q40540353-9F284A7E-E724-4F2E-931B-9C554C17700CQ41873125-0D0BD2F4-92E2-40CC-88B0-744BF843040CQ56888687-231DE5CD-305B-4C84-BAB7-9D7508CDA8C3
P2860
Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Evaluation of the protective e ...... gue 2 virus infection in mice.
@en
Evaluation of the protective e ...... gue 2 virus infection in mice.
@nl
type
label
Evaluation of the protective e ...... gue 2 virus infection in mice.
@en
Evaluation of the protective e ...... gue 2 virus infection in mice.
@nl
prefLabel
Evaluation of the protective e ...... gue 2 virus infection in mice.
@en
Evaluation of the protective e ...... gue 2 virus infection in mice.
@nl
P2093
P1476
Evaluation of the protective e ...... ngue 2 virus infection in mice
@en
P2093
P304
P356
10.4269/AJTMH.1998.58.655
P407
P577
1998-05-01T00:00:00Z